SAN DIEGO, July 15 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company’s Chief Executive Officer, Brian M. Culley, will present to investors as part of the Lippert/Heilshorn & Associates Life Sciences & Medical Technologies On-line Forum on July 20, 2010 at 10:00 a.m. Eastern time.
Interested parties can access a live audio webcast with slide presentation at www.adventrx.com, or from the PrecisionIR site at http://www.informedinvestors.com/IIF/IIF_Forum.asp?ForumID=160292. An archived presentation will be available for 30 days.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a specialty pharmaceutical company whose product candidates are designed to improve the performance of existing cancer treatments by addressing limitations associated principally with their safety and use. More information can be found on the Company’s web site at www.adventrx.com.
SOURCE ADVENTRX Pharmaceuticals, Inc.
